12/17
04:36 pm
okur
OnKure Therapeutics (NASDAQ:OKUR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
OnKure Therapeutics (NASDAQ:OKUR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/6
04:03 pm
okur
OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update
Medium
Report
OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update
11/4
04:05 pm
okur
OnKure Therapeutics to Participate in Upcoming Investor Conferences
Medium
Report
OnKure Therapeutics to Participate in Upcoming Investor Conferences
11/1
01:05 am
okur
OnKure Therapeutics (NASDAQ:OKUR) was upgraded by analysts at
Wall Stree
Low
Report
OnKure Therapeutics (NASDAQ:OKUR) was upgraded by analysts at
Wall Stree